Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
189.53
+1.69 (+0.90%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Oct 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
69
70
Next >
Sweetgreen, Tesla, Digital Realty Trust And A Health Care Stock On CNBC's 'Final Trades'
Today 8:43 EDT
Sweetgreen shares closed at $37.48 during Friday's session. Analysts also discuss Tesla, AbbVie and Digital Realty Trust on 'Final Trades'
Via
Benzinga
What Lies In Store For Healthcare ETFs In Q3 Earnings?
October 27, 2024
The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited.
Via
Talk Markets
Topics
ETFs
3 Dividend Growth Stocks You Can Buy and Hold Forever
October 26, 2024
These healthcare stocks have fantastic dividend track records.
Via
The Motley Fool
Forecasting The Future: 11 Analyst Projections For AbbVie
October 25, 2024
Via
Benzinga
3 High-Yielding Dividend Stocks That Can Be Ideal Buys for Retirees
October 25, 2024
These stocks yield between 2.8% and 3.3% in dividends.
Via
The Motley Fool
Check Out What Whales Are Doing With ABBV
October 24, 2024
Via
Benzinga
Market Analysis: AbbVie And Competitors In Biotechnology Industry
October 17, 2024
Via
Benzinga
Looking Into AbbVie's Recent Short Interest
October 14, 2024
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
October 10, 2024
Via
Benzinga
Beat the Nasdaq With This Cash-Gushing Dividend Stock
October 23, 2024
The company is performing well despite recently losing its biggest growth driver.
Via
The Motley Fool
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
October 23, 2024
These three Vanguard ETFs are worth considering for the long term.
Via
The Motley Fool
Topics
ETFs
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
October 22, 2024
There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle.
Via
Talk Markets
3 Growth Stocks That Could Be Bargain Buys Right Now
October 18, 2024
These stocks trade at less than 20 times their estimated future profits.
Via
The Motley Fool
AbbVie's Options: A Look at What the Big Money is Thinking
October 09, 2024
Via
Benzinga
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
October 07, 2024
Via
Benzinga
FDA Approves AbbVie's Parkinson's Treatment, Medicare Coverage Expected Next Year
October 17, 2024
The FDA approved AbbVie's Vyalev as the first 24-hour subcutaneous infusion therapy for advanced Parkinson's disease, offering improved motor control and reduced symptoms. Approval was based on a...
Via
Benzinga
Exposures
Product Safety
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
October 17, 2024
AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.
Via
Benzinga
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
October 14, 2024
Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb.
Via
Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
October 14, 2024
These companies have compelling track records.
Via
The Motley Fool
Best Pharma Stocks for Long-Term Investors: Growth and Dividends
October 14, 2024
Big pharmaceutical firms may lack the potential for rally driven by a breakout drug like small biotechs, but stability and steady growth remain attractive.
Via
MarketBeat
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
October 14, 2024
Buying these stocks gives you a great chance to beat the benchmark.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Dividend Stock Analysis - Saturday, Oct. 12
October 12, 2024
Johnson & Johnson is a leader in the pharmaceutical, medical device, and consumer products industries. Here are some highlights from a quantitative analysis of the company's stock.
Via
Talk Markets
There Are Only 28 S&P 500 Companies Warren Buffett Can't Buy Outright. Here's the Best of the Bunch for Income Investors.
October 12, 2024
This Dividend King is beyond Buffett's reach to fully acquire and is a great pick for income investors.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
AbbVie Stock Eyes New Highs: Analysts See Strong Growth Potential
October 11, 2024
AbbVie is tracking for a new high that may be reached before the end of the year. Acquisitions fuel the growth outlook, cash flow and capital returns.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
Bio-Path is advancing its obesity treatment BP1001-A and completing trials for BP1002 in acute myeloid leukemia, targeting resistance mechanisms in treatment. Preclinical studies for obesity are set...
Via
Benzinga
Biotech Stocks Poised For Another Big Move In Q4
October 07, 2024
The healthcare sector can be a safe haven if volatility increases.
Via
Talk Markets
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 07, 2024
Via
Benzinga
3 Magnificent Dividend Stocks to Buy in October
October 06, 2024
These dividend stocks are great picks as the fall season gets underway.
Via
The Motley Fool
Billionaires Are Loading Up on This High-Yield Dividend Stock. Should You?
October 06, 2024
Declining earnings haven't scared billionaire investors away from this stock.
Via
The Motley Fool
2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now
October 05, 2024
These companies can lend growth and dividend returns to a long-term investor's portfolio.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.